Zhejiang Xianju Pharmaceutical Co Ltd Cash Flow Quality Index
Zhejiang Xianju Pharmaceutical Co Ltd cash flow quality index. Zhejiang Xianju Pharmaceutical Co Ltd (002332) has a Cash Flow Quality Index of 1.32x as of September 2025. Operating cash flow of CN¥130.05 Million exceeds net income of CN¥98.42 Million, indicating high earnings quality where cash backs reported profits. See financial agility of Zhejiang Xianju Pharmaceutical Co Ltd to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Zhejiang Xianju Pharmaceutical Co Ltd (2006–2025)
Cash flow quality index of Zhejiang Xianju Pharmaceutical Co Ltd from 2006 to 2025. Historical Cash Flow Quality Index for Zhejiang Xianju Pharmaceutical Co Ltd across 20 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore debt repayment capacity of Zhejiang Xianju Pharmaceutical Co Ltd to assess how comfortably operating cash covers total debt obligations.
Zhejiang Xianju Pharmaceutical Co Ltd Cash Flow Quality Index by Year (2006–2025)
Zhejiang Xianju Pharmaceutical Co Ltd cash flow quality index by year from 2006 to 2025. Year-by-year earnings quality comparison for Zhejiang Xianju Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Zhejiang Xianju Pharmaceutical Co Ltd operating cash flow efficiency.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.55x | CN¥247.48 Million | CN¥449.64 Million | ▼ -44.8% |
| 2024 | 1.00x | CN¥398.66 Million | CN¥399.92 Million | ▼ -5.7% |
| 2023 | 1.06x | CN¥595.48 Million | CN¥563.08 Million | ▲ +29.7% |
| 2022 | 0.82x | CN¥609.28 Million | CN¥747.39 Million | ▼ -25.5% |
| 2021 | 1.09x | CN¥676.15 Million | CN¥617.88 Million | ▼ -26.7% |
| 2020 | 1.49x | CN¥789.23 Million | CN¥529.00 Million | ▲ +27.0% |
| 2019 | 1.17x | CN¥519.81 Million | CN¥442.48 Million | ▲ +109.9% |
| 2018 | 0.56x | CN¥193.27 Million | CN¥345.37 Million | ▼ -23.1% |
| 2017 | 0.73x | CN¥167.47 Million | CN¥230.10 Million | ▼ -31.7% |
| 2016 | 1.06x | CN¥155.91 Million | CN¥146.41 Million | ▼ -44.2% |
| 2015 | 1.91x | CN¥199.61 Million | CN¥104.60 Million | ▼ -34.2% |
| 2014 | 2.90x | CN¥141.64 Million | CN¥48.82 Million | ▲ +131.4% |
| 2013 | 1.25x | CN¥63.46 Million | CN¥50.61 Million | ▲ +366.0% |
| 2012 | 0.27x | CN¥33.43 Million | CN¥124.23 Million | ▼ -75.9% |
| 2011 | 1.12x | CN¥147.63 Million | CN¥132.03 Million | ▼ -17.5% |
| 2010 | 1.35x | CN¥155.29 Million | CN¥114.61 Million | ▲ +9.5% |
| 2009 | 1.24x | CN¥104.68 Million | CN¥84.63 Million | ▲ +113.3% |
| 2008 | 0.58x | CN¥36.03 Million | CN¥62.12 Million | ▼ -63.1% |
| 2007 | 1.57x | CN¥96.53 Million | CN¥61.35 Million | ▲ +49.3% |
| 2006 | 1.05x | CN¥53.05 Million | CN¥50.36 Million | — |